Skip to content
← Full study record

NCT01258998 · OUTCOME

Number of Participants With Change in Cytokine Levels With p Values <0.05

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma · Source last updated 2020-11-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Baseline to up to 30 days post-treatment

What was measured

The changes in the cytokine levels from baseline analyzed by Wilcoxon signed rank test. P values \< 0.05 were considered statistically significant.

Groups in this outcome

Akt Inhibitor MK2206

Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Akt Inhibitor MK220636

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Akt Inhibitor MK220636Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        36
denoms
  1. counts
    1. group Id
      OG000
      value
      36
    units
    Participants
description
The changes in the cytokine levels from baseline analyzed by Wilcoxon signed rank test. P values \< 0.05 were considered statistically significant.
groups
  1. description
    Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.
    id
    OG000
    title
    Akt Inhibitor MK2206
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Baseline to up to 30 days post-treatment
title
Number of Participants With Change in Cytokine Levels With p Values <0.05
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice